Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice

European Journal of Pharmacology

Volumn 715, Issue 1-3, 2013, Pages 111-116

  Kinsey, Steven G ^a   Cole, Erica C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cannabinoid; Cyclooxygenase; Diclofenac; Gastric inflammation; NSAID dyspepsia; Tetrahydrocannabinol

Indexed keywords

DICLOFENAC; DRONABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HYPOTHERMIA; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH PROTECTION; STOMACH ULCER; WATER IMMERSION;

CANNABINOID; CYCLOOXYGENASE; DICLOFENAC; GASTRIC INFLAMMATION; NSAID DYSPEPSIA; TETRAHYDROCANNABINOL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; CATALEPSY; DICLOFENAC; DRONABINOL; GASTROINTESTINAL HEMORRHAGE; HYPOTHERMIA; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL;

EID: 84885485892     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.001     Document Type: Article

References (36)

1. Adami, M., Frati, P., Bertini, S., Kulkarni-Narla, A., Brown, D.R., de Caro, G., Coruzzi, G., Soldani, G., 2002. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br. J. Pharmacol. 135, 1598-1606. (Pubitemid 36132693)
2. Adami, M., Zamfirova, R., Sotirov, E., Tashev, R., Dobrinova, Y., Todorov, S., Coruzzi, G., 2004. Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat. Brain Res. Bull. 64, 357-361. (Pubitemid 39550772)
3. Balenga, N.A., Aflaki, E., Kargl, J., Platzer, W., Schroder, R., Blattermann, S., Kostenis, E., Brown, A.J., Heinemann, A., Waldhoer, M., 2011. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res. 21, 1452-1469.
4. Colquhoun, D., 1971. Lectures on Biostatistics; An Introduction to Statistics with Applications in Biology and Medicine. Clarendon Press, Oxford.
5. Dembinski, A., Warzecha, Z., Ceranowicz, P., Dembinski, M., Cieszkowski, J., Pawlik, W.W., Konturek, S.J., Tomaszewska, R., Hladki, W., Konturek, P.C., 2006. Cannabinoids in acute gastric damage and pancreatitis. J. Physiol. Pharmacol. 57 (Suppl. 5), 137-154. (Pubitemid 46569790)
6. Di Marzo, V., Piscitelli, F., 2011. Gut feelings about the endocannabinoid system. Neurogastroenterol. Motil. 23, 391-398.
7. Falenski, K.W., Thorpe, A.J., Schlosburg, J.E., Cravatt, B.F., Abdullah, R.A., Smith, T.H., Selley, D.E., Lichtman, A.H., Sim-Selley, L.J., 2010. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsycho-pharmacology 35, 1775-1787.
8. Gaoni, Y., Mechoulam, R., 1964. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647.
9. Germano, M.P., D'Angelo, V., Mondello, M.R., Pergolizzi, S., Capasso, F., Capasso, R., Izzo, A.A., Mascolo, N., De Pasquale, R., 2001. Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch. Pharmacol. 363, 241-244. (Pubitemid 32200333)
10. Izzo, A.A., Sharkey, K.A., 2010. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol. Ther. 126, 21-38.
11. Kinsey, S.G., Mahadevan, A., Zhao, B., Sun, H., Naidu, P.S., Razdan, R.K., Selley, D.E., Imad Damaj, M., Lichtman, A.H., 2011a. The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology 60, 244-251.
12. Kinsey, S.G., Nomura, D.K., O'Neal, S.T., Long, J.Z., Mahadevan, A., Cravatt, B.F., Grider, J.R., Lichtman, A.H., 2011b. Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. J. Pharmacol. Exp. Ther. 338, 795-802.
13. Kinsey, S.G., Wise, L.E., Ramesh, D., Abdullah, R., Selley, D.E., Cravatt, B.F., Lichtman, A.H., 2013. Repeated low dose administration of the monoacylglycerol lipase inhibitor JZL184 retains CB1 receptor mediated antinociceptive and gastro-protective effects. J. Pharmacol. Exp. Ther.
14. Lanas, A., 2009. Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer. Am. J. Med. Sci. 338, 96-106.
15. Lodato, F., Azzaroli, F., Turco, L., Mazzella, N., Buonfiglioli, F., Zoli, M., Mazzella, G., 2010. Adverse effects of proton pump inhibitors. Best Pract. Res. Clin. Gastro-enterol. 24, 193-201.
16. Long, L.E., Chesworth, R., Huang, X.F., McGregor, I.S., Arnold, J.C., Karl, T., 2010. A behavioural comparison of acute and chronic delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int. J. Neuropsychopharmacol. 13, 861-876.
17. Mackie, K., 2006. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 46, 101-122. (Pubitemid 43271185)
18. Mechoulam, R., Parker, L.A., 2013. The endocannabinoid system and the brain. Annu. Rev. Psychol. 64, 21-47.
19. Musumba, C., Pritchard, D.M., Pirmohamed, M., 2009. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment. Pharmacol. Ther. 30, 517-531.
20. Nadulski, T., Sporkert, F., Schnelle, M., Stadelmann, A.M., Roser, P., Schefter, T., Pragst, F., 2005. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J. Anal. Toxicol. 29, 782-789. (Pubitemid 41803377)
21. Naidu, P.S., Booker, L., Cravatt, B.F., Lichtman, A.H., 2009. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception. J. Pharmacol. Exp. Ther. 329, 48-56.
22. Nalin, D.R., Levine, M.M., Rhead, J., Bergquist, E., Rennels, M., Hughes, T., O'Donnel, S., Hornick, R.B., 1978. Cannabis, hypochlorhydria, and cholera. Lancet 2, 859-862.
23. Nomura, D.K., Morrison, B.E., Blankman, J.L., Long, J.Z., Kinsey, S.G., Marcondes, M.C., Ward, A.M., Hahn, Y.K., Lichtman, A.H., Conti, B., Cravatt, B.F., 2011. Endocanna-binoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334, 809-813.
24. Patrono, C., Baigent, C., 2009. Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. Mol. Interv. 9, 31-39.
25. Pazos, M.R., Tolon, R.M., Benito, C., Rodriguez, C.F., Gorgojo, J.J., Nevado, M., Alvarez, M., Arias, F., Almodovar, F., Fernandez, M.T., Lledo, J.L., Gonzalez, S., Fernandez-Ruiz, J.J., Romero, J., 2008. Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa. J. Histochem. Cytochem. 56, 511-516. (Pubitemid 351556493)
26. Pertwee, R.G., 2001. Cannabinoids and the gastrointestinal tract. Gut 48, 859-867. (Pubitemid 32476991)
27. Pertwee, R.G., 2012. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos. Trans. R. Soc. London B Biol. Sci. 367, 3353-3363.
28. Sasso, O., Bertorelli, R., Bandiera, T., Scarpelli, R., Colombano, G., Armirotti, A., Moreno-Sanz, G., Reggiani, A., Piomelli, D., 2012. Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions. Pharmacol. Res. 65, 553-563.
29. Sawzdargo, M., Nguyen, T., Lee, D.K., Lynch, K.R., Cheng, R., Heng, H.H., George, S.R., O'Dowd, B.F., 1999. Identification and cloning of three novel human G proteincoupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res. Mol. Brain Res. 64, 193-198. (Pubitemid 29052470)
30. Schicho, R., Bashashati, M., Bawa, M., McHugh, D., Saur, D., Hu, H.M., Zimmer, A., Lutz, B., Mackie, K., Bradshaw, H.B., McCafferty, D.M., Sharkey, K.A., Storr, M., 2011. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm. Bowel Dis. 17, 1651-1664.
31. Schicho, R., Storr, M., 2012. A potential role for GPR55 in gastrointestinal functions. Curr. Opin. Pharmacol. 12, 653-658.
32. Schlosburg, J.E., Blankman, J.L., Long, J.Z., Nomura, D.K., Pan, B., Kinsey, S.G., Nguyen, P.T., Ramesh, D., Booker, L., Burston, J.J., Thomas, E.A., Selley, D.E., Sim-Selley, L.J., Liu, Q.S., Lichtman, A.H., Cravatt, B.F., 2010. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 13, 1113-1119.
33. Shujaa, N., Zadori, Z.S., Ronai, A.Z., Barna, I., Mergl, Z., Mozes, M.M., Gyires, K., 2009. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. J. Physiol. Pharmacol. 60 (Suppl. 7), 93-100.
34. Singh, G., 1998. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am. J. Med. 105, 31S-38S. (Pubitemid 28378015)
35. Sofia, R.D., Diamantis, W., Harrison, J.E., Melton, J., 1978. Evaluation of antiulcer activity of delta9-tetrahydrocannabinol in the Shay rat test. Pharmacology 17, 173-177. (Pubitemid 9007890)
36. Wiley, J.L., Martin, B.R., 2003. Cannabinoid pharmacological properties common to other centrally acting drugs. Eur. J. Pharmacol. 471, 185-193. (Pubitemid 36776413)